Metraipolis › archive › dc_45980b781bd0
Transitioning Between Treprostinil Formulations: Evidence and Strategies — Europe PMC PMID:41212478
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41212478
- DOI
- 10.1007/s12325-[numero omesso]-6
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T16:48:46.882Z
- SHA-256 of the archived text
ec87f78c93dc396b3781fab2c4924401e58fa84715b1cd4355e7f990a3ff729c- Stable URL of this page
https://metraipolis.com/documento/dc_45980b781bd0
How to cite
Transitioning Between Treprostinil Formulations: Evidence and Strategies — Europe PMC PMID:41212478 — Europe PMC (en), https://europepmc.org/article/MED/41212478 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_45980b781bd0 (Metraipolis archive dc_45980b781bd0, sha256 ec87f78c93dc396b3781fab2c4924401e58fa84715b1cd4355e7f990a3ff729c)
BibTeX
@misc{dc45980b781bd0,
title = {Transitioning Between Treprostinil Formulations: Evidence and Strategies — Europe PMC PMID:41212478},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41212478},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_45980b781bd0; sha256 ec87f78c93dc396b3781fab2c4924401e58fa84715b1cd4355e7f990a3ff729c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41212478. Agents can read the archived copy with the MCP tool read_document.